| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
-Positive and -Negative Mouse Mammary Tumors with High Frequency of Metastasis
1 Departments of Developmental and Cell Biology, 2 Biological Chemistry, and 3 Ecology and Evolutionary Biology, University of California, Irvine, California; 4 The Salk Institute for Biological Studies, La Jolla, California; 5 Department of Biomedical Sciences, Cornell University, Ithaca, New York; 6 Department of Medicine and Department of Molecular and Cellular Biology, Breast Center, Baylor College of Medicine, Houston, Texas; and 7 Center for Comparative Medicine, University of California, Davis, California
Approximately 70% of human breast cancers are estrogen receptor
(ER
)-positive, but the origins of ER
-positive and -negative tumors remain unclear. Hormonal regulation of mammary gland development in mice is similar to that in humans; however, most mouse models produce only ER
-negative tumors. In addition, these mouse tumors metastasize at a low rate relative to human breast tumors. We report here that somatic mutations of p53 in mouse mammary epithelial cells using the Cre/loxP system leads to ER
-positive and -negative tumors. p53 inactivation under a constitutive active WAPCrec in prepubertal/pubertal mice, but not under MMTVCre in adult mice, leads to the development of ER
-positive tumors, suggesting that target cells or developmental stages can determine ER
status in mammary tumors. Importantly, these tumors have a high rate of metastasis. An inverse relationship between the number of targeted cells and median tumor latency was also observed. Median tumor latency reaches a plateau when targeted cell numbers exceed 20%, implying the existence of saturation kinetics for breast carcinogenesis. Genetic alterations commonly observed in human breast cancer including c-myc amplification and Her2/Neu/erbB2 activation were seen in these mouse tumors. Thus, this tumor system reproduces many important features of human breast cancer and provides tools for the study of the origins of ER
-positive and -negative breast tumors in mice.
This article has been cited by other articles:
![]() |
D. Medina, F. Kittrell, J. Hill, Y. Zhang, S. G. Hilsenbeck, R. Bissonette, and P. H. Brown Prevention of Tumorigenesis in p53-Null Mammary Epithelium by Rexinoid Bexarotene, Tyrosine Kinase Inhibitor Gefitinib, and Celecoxib Cancer Prevention Research, February 1, 2009; 2(2): 168 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Llaguno, J. Chen, C.-H. Kwon, and L.F. Parada Neural and Cancer Stem Cells in Tumor Suppressor Mouse Models of Malignant Astrocytoma Cold Spring Harb Symp Quant Biol, November 6, 2008; (2008) sqb.2008.73.005v1. [Abstract] [PDF] |
||||
![]() |
H. Song, K. Shahverdi, D. L. Huso, Y. Wang, J. J. Fox, R. F. Hobbs, B. Gimi, K. L. Gabrielson, M. G. Pomper, B. M. Tsui, et al. An Immunotolerant HER-2/neu Transgenic Mouse Model of Metastatic Breast Cancer Clin. Cancer Res., October 1, 2008; 14(19): 6116 - 6124. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shafee, C. R. Smith, S. Wei, Y. Kim, G. B. Mills, G. N. Hortobagyi, E. J. Stanbridge, and E. Y-H. P. Lee Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53-Mediated Mouse Mammary Tumors Cancer Res., May 1, 2008; 68(9): 3243 - 3250. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Kwon, D. Zhao, J. Chen, S. Alcantara, Y. Li, D. K. Burns, R. P. Mason, E. Y.-H. P. Lee, H. Wu, and L. F. Parada Pten Haploinsufficiency Accelerates Formation of High-Grade Astrocytomas Cancer Res., May 1, 2008; 68(9): 3286 - 3294. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shai, H. C. Pitot, and P. F. Lambert p53 Loss Synergizes with Estrogen and Papillomaviral Oncogenes to Induce Cervical and Breast Cancers Cancer Res., April 15, 2008; 68(8): 2622 - 2631. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Choi, S. H. Roh, H. G. Kim, E. H. Han, H. G. Jeong, and K. W. Kang Enhanced expression of aromatase in p53-inactivated mammary epithelial cells Endocr. Relat. Cancer, March 1, 2008; 15(1): 139 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Deeb, A. M. Michalowska, C.-y. Yoon, S. M. Krummey, M. J. Hoenerhoff, C. Kavanaugh, M.-c. Li, F. J. Demayo, I. Linnoila, C.-x. Deng, et al. Identification of an Integrated SV40 T/t-Antigen Cancer Signature in Aggressive Human Breast, Prostate, and Lung Carcinomas with Poor Prognosis Cancer Res., September 1, 2007; 67(17): 8065 - 8080. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Poole, Y. Li, Y. Kim, S.-C. J. Lin, W.-H. Lee, and E. Y.-H. P. Lee Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist Science, December 1, 2006; 314(5804): 1467 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Cardiff Epithelial to Mesenchymal Transition Tumors: Fallacious or Snail's Pace? Clin. Cancer Res., December 15, 2005; 11(24): 8534 - 8537. [Full Text] [PDF] |
||||
![]() |
S. W.P. Wijnhoven, E. Zwart, E. N. Speksnijder, R. B. Beems, K. P. Olive, D. A. Tuveson, J. Jonkers, M. M. Schaap, J. van den Berg, T. Jacks, et al. Mice Expressing a Mammary Gland-Specific R270H Mutation in the p53 Tumor Suppressor Gene Mimic Human Breast Cancer Development Cancer Res., September 15, 2005; 65(18): 8166 - 8173. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mo, J. Cheng, E. Y.-H. P. Lee, T.-T. Sun, and X.-R. Wu Gene deletion in urothelium by specific expression of Cre recombinase Am J Physiol Renal Physiol, September 1, 2005; 289(3): F562 - F568. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kuperwasser, S. Dessain, B. E. Bierbaum, D. Garnet, K. Sperandio, G. P. Gauvin, S. P. Naber, R. A. Weinberg, and M. Rosenblatt A Mouse Model of Human Breast Cancer Metastasis to Human Bone Cancer Res., July 15, 2005; 65(14): 6130 - 6138. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Medina, F. S. Kittrell, J. Hill, A. Shepard, G. Thordarson, and P. Brown Tamoxifen Inhibition of Estrogen Receptor-{alpha}-Negative Mouse Mammary Tumorigenesis Cancer Res., April 15, 2005; 65(8): 3493 - 3496. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Meniel, T. Hay, A. Douglas-Jones, O. J. Sansom, and A. R. Clarke Mutations in Apc and p53 Synergize to Promote Mammary Neoplasia Cancer Res., January 15, 2005; 65(2): 410 - 416. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |